Related Experiment Video

Updated: Aug 11, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

Serum C3 and C4 complement components in ulcerative colitis and Crohn's disease

M Ward, M A Eastwood

    Digestion
    |January 1, 1975
    PubMed

    Insights

    Serum C4 complement levels were elevated in Crohn's disease patients. In ulcerative colitis, higher C3 and C4 levels correlated with disease severity and persisted post-surgery, indicating potential roles in inflammatory bowel disease.

    Area of Science:

    • Immunology
    • Gastroenterology
    • Clinical Chemistry

    Background:

    • Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), involves complex immune dysregulation.
    • The complement system, a crucial part of innate immunity, plays a role in inflammation and tissue damage in various diseases.
    • Alterations in complement component levels may serve as biomarkers for disease activity or progression in IBD.

    Purpose of the Study:

    • To investigate serum concentrations of complement components C3 and C4 in patients diagnosed with Crohn's disease and ulcerative colitis.
    • To determine if C3 and C4 levels correlate with disease status, severity, or extent in these IBD subtypes.
    • To explore the long-term behavior of C4 levels following surgical intervention, such as colectomy.

    Main Methods:

    • Serum samples were collected from patients with CD and UC, as well as from healthy control subjects.
    • Quantitative analysis of C3 and C4 complement components was performed using established laboratory assays.
    • Statistical comparisons were made between patient groups and controls, and correlations with clinical disease parameters were assessed.

    Main Results:

    • Serum C4 concentrations were found to be significantly elevated in patients with Crohn's disease compared to healthy controls.
    • In ulcerative colitis patients, significantly higher concentrations of both C3 and C4 were observed, particularly in those with severe or extensive disease.
    • Elevated C4 levels were noted to persist for years even after a total colectomy in some ulcerative colitis patients.

    Conclusions:

    • Serum C4 elevation is a notable finding in Crohn's disease.
    • Complement components C3 and C4 may serve as indicators of disease severity and extent in ulcerative colitis.
    • Persistent elevation of C4 post-colectomy suggests a long-term complement system activation in some UC patients, warranting further investigation into its clinical significance.

    More Related Videos

    Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis08:58

    Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

    Published on: January 5, 2017

    Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry07:20

    Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry

    Published on: May 19, 2020

    Related Concept Videos

    Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

    Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

    Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
    Inflammatory Bowel Disease I: Ulcerative Colitis01:27

    Inflammatory Bowel Disease I: Ulcerative Colitis

    Introduction
    Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
    Risk Factors
    The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
    Inflammatory Bowel Disease II: Crohn's Disease01:30

    Inflammatory Bowel Disease II: Crohn's Disease

    Introduction
    Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
    Crohn's disease
    Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
    Inflammatory Bowel Disease II: Ulcerative Colitis01:20

    Inflammatory Bowel Disease II: Ulcerative Colitis

    Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
    Inflammatory Bowel Disease III: Crohn's Disease01:25

    Inflammatory Bowel Disease III: Crohn's Disease

    Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
    Inflammatory Bowel Disease IV: Clinical Manifestations01:20

    Inflammatory Bowel Disease IV: Clinical Manifestations

    Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...